Diagnosis, Classification and Management of Mast Cell Activation Syndromes (MCAS) in the Era of Personalized Medicine
Mast cell activation (MCA) is seen in a variety of clinical contexts and pathologies, including IgE-dependent allergic inflammation, other immunologic and inflammatory reactions, primary mast cell (MC) disorders, and hereditary alpha tryptasemia (HAT). MCA-related symptoms range from mild to severe...
Main Authors: | Peter Valent, Cem Akin, Boguslaw Nedoszytko, Patrizia Bonadonna, Karin Hartmann, Marek Niedoszytko, Knut Brockow, Frank Siebenhaar, Massimo Triggiani, Michel Arock, Jan Romantowski, Aleksandra Górska, Lawrence B. Schwartz, Dean D. Metcalfe |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/23/9030 |
Similar Items
-
A Challenge for Allergologist: Application of Allergy Diagnostic Methods in Mast Cell Disorders
by: Jan Romantowski, et al.
Published: (2021-02-01) -
Genetic Regulation of Tryptase Production and Clinical Impact: Hereditary Alpha Tryptasemia, Mastocytosis and Beyond
by: Bettina Sprinzl, et al.
Published: (2021-02-01) -
Mast Cell Activation Disorders
by: Arianna Giannetti, et al.
Published: (2021-01-01) -
Mast cells and tryptase. Modern aspects
by: D. Sh. Macharadze
Published: (2021-12-01) -
Clinical Impact of Inherited and Acquired Genetic Variants in Mastocytosis
by: Boguslaw Nedoszytko, et al.
Published: (2021-01-01)